![Anke Post](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 99 260 $ al 30/06/2026
Anke Post is currently Chief Medical Officer at GeNeuro SA (Switzerland) since 2024.
Formerly, Chief Medical Officer at AC Immune SA from 2024 to 2025.
Education includes doctorates from Ludwig-Maximilians-Universität München and the University of Münster.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AC IMMUNE SA 0,04 % | 01/03/2026 | 41.706 ( 0,04 % ) | 99 260 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENEURO SA | Director Técnico/Científico/I+D | 05/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| AC IMMUNE SA | Director Técnico/Científico/I+D | 01/06/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeNeuro SA (Switzerland)
 GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
